Page 162«..10 20..161162163 164..170 180..»

Category Archives: Stem Cell Therapy

Half-full, Half-empty Editorial on California Stem Cell Agency

Posted: February 19, 2013 at 8:18 pm

The California stem cell agency's
editorial road show paid off a bit again this week with a mildly
approving editorial in the Oakland Tribune.

The Feb.18 piece said that the presence
of Jonathan Thomas, a Los Angeles bond financier, as chairman of the
$3 billion agency has improved things, compared to the reign of Bob
Klein, who “built a protective shield” around the agency's
governing board and prevented action to deal with obvious
conflict-of-interest problems.

The newspaper also said that “to some
extent” the agency has brought “cutting edge” scientists to the
state and helped boost the stem cell field.

That was the half-full side of the
editorial. The half-empty side included the headline.

“California
must get its stem cell house in order”

The editorial continued:

“...{T)he agency must prove that it
understands how to properly handle the public's money. …. If
the stem cell agency can establish a record as a good steward of
public dollars to finance brilliant science, it can continue to play
a useful role in stimulating and guiding research to bring the
potential cures from stem cell research to fruition.

“If it cannot do that, it will be
just another expensive Tyrannosaurus rex.”

Thomas and company are knocking on
editorial doors around the state in hopes of building support for the
board's modest – some might say inadequate – response to
recommendations for sweeping changes at the agency.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/tMt6gs55Yvs/half-full-half-empty-editorial-on.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off

Stem Cell Therapy – Arthritis Therapy – Video

Posted: February 19, 2013 at 11:44 am

Stem Cell Therapy - Arthritis Therapy
Stem cell therapy for dogs, cats, and horses has been around for a few years. But as companies compete, the technology keeps improving. And today, a Hillsborough County vet clinic became only the second in the Bay Area to offer same-day procedures.

By: EhrlichAnimalHospita

Go here to read the rest:
Stem Cell Therapy - Arthritis Therapy - Video

Stem Cell Therapy – Ehrlich Animal Hospital’s Arthritis Therapy Center – Video

Posted: February 19, 2013 at 11:44 am

Stem Cell Therapy - Ehrlich Animal Hospital #39;s Arthritis Therapy Center
Ehrlich Animal Hospital offers several degrees of specialty arthritis therapies and treatments that may not be currently available at other local animal hospitals. Our hospital is unique in that we offer cutting edge arthritis therapy technologies: therapeutic laser treatments, injectable medications and oral medications to reduce inflammation and discomfort.

By: EhrlichAnimalHospita

Posted in Cell Therapy, Stem Cell Therapy | Comments Off

Testimonials – Stem Cell Therapy – Ehrlich Animal Hospital’s Arthritis Therapy Center – Video

Posted: February 19, 2013 at 11:44 am

Testimonials - Stem Cell Therapy - Ehrlich Animal Hospital #39;s Arthritis Therapy Center
We love your pets and we know that you do too. Let us ensure that your pets live the longest, healthiest lives possible. Thank you for your continued confidence in our love and concern for your pet #39;s health and longevity.

By: EhrlichAnimalHospita

Link:
Testimonials - Stem Cell Therapy - Ehrlich Animal Hospital's Arthritis Therapy Center - Video

Posted in Cell Therapy, Stem Cell Therapy | Comments Off

Learn more about stem cell therapy at Vail Athletic Club Friday

Posted: February 19, 2013 at 11:44 am

VAIL The Vail Athletic Club, part of the Vail Vitality Center wellness experience at Vail Mountain Lodge, introduces a lecture which offers an in-depth look at new developments in cellular therapy for the treatment of joint pain. Stem Cell Therapy is a groundbreaking procedure that uses a patient's own stem cells to repair or replace damaged joint tissue. Dr. Scott Brandt of ThriveMD in Edwards is one of few physicians in the country trained in this procedure. Brandt will present details about this innovative new therapy at the Vail Athletic Club on Friday at 6 p.m.

Stem cell therapy is a minimally invasive procedure that begins with harvesting a patient's stem cells from his or her own fat reserves most often from the abdominal region. The tissue is isolated in a state-of-the-art cell-processing laboratory. The cells are then injected into the damaged joint using a minimally invasive technique with the assistance of fluoroscopic guidance. Once injected, the cells can sense proteins generated from cartilage damage and, in response, those cells have the ability to make chondrocytes cells found in healthy cartilage. This new procedure relieves the pain and limitations of arthritic joint disease without resorting to an invasive joint replacement surgery.

Brandt will discuss the process of isolating autologous adipose derived stem cells, the details of the procedure, and answer questions about this treatment for cartilage, ligament and tendon injuries.

For more information or to register call 970-476-7960. The lecture is offered as a fundraiser for the Eagle County Education Foundation and a $15 donation is suggested. Advance reservations are required and space is limited.

Visit link:
Learn more about stem cell therapy at Vail Athletic Club Friday

Posted in Cell Therapy, Stem Cell Therapy | Comments Off

Testimonials – Stem Cell Therapy – Ehrlich Animal Hospital's Arthritis Therapy Center – Video

Posted: February 19, 2013 at 11:41 am

By: EhrlichAnimalHospita

Posted in Stem Cell Therapy | Comments Off

Beckers Muscular Dystrophy After Stem Cell Therapy in Mumbai India – Video

Posted: February 18, 2013 at 9:47 am

Beckers Muscular Dystrophy After Stem Cell Therapy in Mumbai India
He is a 12 year old and a known case of BMD with history of gradual onset of progressive lower extremities muscle weakness since age of 7 years with complaints of difficulty in climbing stairs, getting up from floor. Weakness even progressed to upper extremities with difficulty in overhead activities and frequent falls. No family history. On examination, he has grade 3 #713; muscle power in proximal muscles of both upper extremities and lower extremities and 4 in distal muscles of both upper extremities and lower extremities. He has bilateral pseudohypertrophy of calf muscles and walks on toes. Neurologically, he is hypotonic and hyporeflexic. Functionally, he is independent in most of the ADL, needs assistance in lower body dressing. On FIM he score 109. After Stem Cell Treatment 1. Reports overall feeling of freshness and energetic. 2. Can manage to walk on heels. Earlier he would walk on toes. 3. Posture has improved. Earlier he would walk with lordosis. 4. Earlier he would need maximum support for stair climbing from both railing and one hand on knee, now only uses railing to climb stairs. 5. Stamina has improved and he has increased level of confidence. 6. Sit to stand and stand to sit transfers requires less efforts. 7. Can perform overhead activities with ease and maintains for a longer time. 8. Is more active than before. 9. Speech is clear and loud followed by deep inhalation and slow rate with prolongation technique. 10. Secondary behaviors also reduced like reduced ...

By: neurogenbsi

View post:
Beckers Muscular Dystrophy After Stem Cell Therapy in Mumbai India - Video

Posted in Cell Therapy, Stem Cell Therapy | Comments Off

Hypoxic Ischaemic Brain Injury Improvement After Stem Cell Therapy in Mumbai India – Video

Posted: February 18, 2013 at 9:47 am

Hypoxic Ischaemic Brain Injury Improvement After Stem Cell Therapy in Mumbai India
He is a case of Hypoxic Brain Injury since 4 years. Because of high grade fever of "chikungunya", he got cardiac arrest and went into coma for 1 year. During comatose stage, he had sacral and Greater Trochanter sores which are all recovered and he has developed myositis ossification at bilateral hip and right elbow. Hip myositis ossification was removed surgically. After comatose stage, he has recovered in speech and voluntary control. He has developed rigidity in trunk and lower extremities. In 2011,he had history of fall while walking and had right femur shaft fracture which was treated surgically with plate and screws in place. Neurologically, he is hypertonic and hyperreflexic. On examination, he has restricted range of motion of bilateral hip, knee and ankle and right elbow. Voluntary control of lower extremities is poor while voluntary control of upper extremities is fair. He has rigidity in bilateral lower extremities and spasticity of grade 2 in upper extremities muscles. Patient is dependent for all ADL. On FIM he scores 30. After Stem Cell Treatment 1. He feels ease in getting up from supine to sit. 2. He can sit straight for some time (5-10 minutes) ,earlier easily stoop in 5-10 seconds. 3. His sitting balance is improved than before, earlier had fear to tilt sideways. 4. His spasticity in lower limb has reduced. 5. His speech has become clear and with proper pauses. 6. He can do roll over on bed with ease and less assistance from caretaker than before. Stem ...

By: neurogenbsi

Posted in Cell Therapy, Stem Cell Therapy | Comments Off

Autism Improvement After Stem Cell Therapy in Mumbai India – Video

Posted: February 18, 2013 at 9:47 am

Autism Improvement After Stem Cell Therapy in Mumbai India
He is a known case of Autism with history of full term normal delivery, cried immediately after birth. He had near normal motor milestones with delayed speech. On examination, he has poor eye contact, poor concentration, poor attention span, poor language command. He is stubborn and aggressive (decreased with rehabilitation). He goes to normal school and had good memory but poor in social communication. On ISAA scale he scores 90. On WeeFIM, he scores 77. After Stem Cell Therapy Psychology assessment: 1) His attention and concentration has improved by 25%. Previously his remedial educator would take him in a group session as he would do an activity only under a competitive spirit whereas now he can even study alone. 2) Eye contact has improved. 3) His quantity and quality of vocabulary has improved about 25%. 4) Now, he is able to form sentences of 4-5 words whereas previously his speech was bisyllables. 5) Now he is able to formulate meaningful sentences and have a meaningful conversation. 6) Now he is learning new mathematical concepts and mother and teachers feel that study wise there are real good improvements. 7) Memory has improved ie now he is able to reproduce and recollect whatever has been taught to him in the school. 8) Speech therapist mentioned that he now does not require speech therapy whereas he now requires OT and remedial education. 9) Social interaction is better ie now he can initiate and engage himself and other people into an activity or conversation ...

By: neurogenbsi

Excerpt from:
Autism Improvement After Stem Cell Therapy in Mumbai India - Video

Posted in Stem Cell Therapy | Comments Off

Time For Public Disclosure of Financial Interests of Stem Cell Agency Reviewers

Posted: February 17, 2013 at 9:47 pm

Should the scientists who evaluate
and score the applications for $3 billion in taxpayer funds be
required to publicly disclose their financial interests?

No, says the California stem cell
agency, despite concerns by the state auditor and the state's Fair
Political Practices Commission (FPPC) that date back at least six
years. The agency says that its governing board makes the decisions
on the applications – not the grant reviewers – and that the
members of the board fully disclose their economic interests.

However, last month the agency produced
a document that sheds new light on the issue. The document confirms
that the board rubber-stamps virtually all the reviewers' decisions,
going along with their actions 98 percent of the time. The board
exercised independent judgment on 28 out of 1,355 applications.

Why is this important? Here is what the state auditor said in 2007,

“(T)he FPPC believes that, under
state regulations, working group members (including grant reviewers)
may act as decision makers if they make substantive recommendations
that are, over an extended period, regularly approved without
significant amendment or modification by the committee. Thus, as
decision makers, working group members would need to be subject to
the conflict-of-interest code. This would mean that working groups
would be subject not only to the (public) financial disclosure requirements of
the Political Reform Act but also to the prohibition against a member
participating in a government decision in which that member has a
disqualifying financial interest and may be subject to the penalties
that may be imposed on individuals who violate that act.”

The auditor recommended that the stem
cell agency seek an attorney general's opinion on the matter, a
recommendation the agency agency summarily dismissed seven months later..

Then interim CIRM
President Richard Murphy, a former member of the agency's board and
former president of the Salk Institute, replied to the auditor:

"We have given careful
consideration to your recommendation and have decided it is not
appropriate to implement at this time. In almost three years of
operation and approval of four rounds of grants, the recommendations
of the CIRM working groups have never been routinely and/or regularly
adopted by the ICOC. Until the time that such a pattern is detected,
the question you suggest we raise with the attorney general is
entirely hypothetical, and is therefore not appropriate for
submission. We will, however, continue to monitor approvals for such
a pattern and will reconsider our decision if one emerges."

In the four rounds mentioned in
Murphy's response, 100 percent of reviewer decisions were
rubber-stamped by the board. In the other two rounds, the percentage
was 95 and 96 percent.

Currently, scientific grant reviewers at the stem cell agency, all of whom are from out-of-state, disclose financial and professional conflicts
of interest in private to selected CIRM officials. (See policy here.)
From time to time, grant reviewers are excused from evaluating
specific applications.

The CIRM governing board has resisted
requiring public disclosure of the interests of reviewers. The subject
has come up several times, but board members have been concerned
about losing reviewers who would not be pleased about disclosing
their financial interests. Nonetheless, disclosure of interests among researchers is becoming routine in scientific research articles. Many universities, including
Stanford, also require public disclosure of financial interests of
their researchers. Stanford says,

“No matter what the circumstances --
if an independent observer might reasonably question whether the
individual's professional actions or decisions are determined by
considerations of personal financial gain, the relationship should be
disclosed to the public during presentations, in publications,
teaching or other public venues.”

The latest version of CIRM's conflict
of interest rules are under review by the FPPC. They do not include
any changes in public disclosure for grant reviewers. In view of the
new information that confirms that reviewers are making 98 percent of
the decisions on who gets the taxpayers' dollars, it would seem that it is long past due for public disclosure of both financial and professional
interests of reviewers. Indeed, given the nature of scientific
research and the tiny size of the stem cell community, disclosure of
professional interests may be more important than financial
disclosures.

As Francis S. Collins, head of the NIH,
said concerning his organization's own strengthening of disclosure requirements,

"The public trust in what we do is
just essential, and we cannot afford to take any chances with the
integrity of the research process."

Here is the CIRM document concerning
reviewers' decisions and governing board action. The table has not
been posted on the CIRM website, but it was prepared for last month's
meeting dealing with the Institute of Medicine's recommendations for
sweeping changes at the agency, especially related to conflicts of
interest.

CIRM Board's
Record on Reviewer Grant Decisions by

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/oma-MLcANoY/time-for-public-disclosure-of-financial.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off

Page 162«..10 20..161162163 164..170 180..»

Category Archives: Stem Cell Therapy

Half-full, Half-empty Editorial on California Stem Cell Agency

Stem Cell Therapy – Arthritis Therapy – Video

Stem Cell Therapy – Ehrlich Animal Hospital’s Arthritis Therapy Center – Video

Testimonials – Stem Cell Therapy – Ehrlich Animal Hospital’s Arthritis Therapy Center – Video

Learn more about stem cell therapy at Vail Athletic Club Friday

Testimonials – Stem Cell Therapy – Ehrlich Animal Hospital's Arthritis Therapy Center – Video

Beckers Muscular Dystrophy After Stem Cell Therapy in Mumbai India – Video

Hypoxic Ischaemic Brain Injury Improvement After Stem Cell Therapy in Mumbai India – Video

Autism Improvement After Stem Cell Therapy in Mumbai India – Video

Time For Public Disclosure of Financial Interests of Stem Cell Agency Reviewers

Categories

Archives

Recommended Sites

Contact Us

Recent Posts